Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer

(MedPage Today) -- Two new immunotherapy-chemotherapy options are now approved for patients with primary advanced or recurrent endometrial cancer, the FDA announced.
On Monday, the agency approved the PD-1-directed immune checkpoint inhibitor...